Müller, 2007, Curr Opin Mol Ther, 9, 319
Chames, 2009, Curr Opin Drug Discov Develop, 12, 276
Ruf, 2001, Blood, 98, 2526, 10.1182/blood.V98.8.2526
Wu, 2007, Nat Biotechnol, 25, 1290, 10.1038/nbt1345
Baeuerle, 2009, Curr Opin Mol Ther, 11, 22
Kellner, 2008, J Immunother, 31, 871, 10.1097/CJI.0b013e318186c8b4
Rossi, 2003, Clin Cancer Res, 9, 3886S
Kontermann, 2005, Acta Pharmacol Sin, 26, 1, 10.1111/j.1745-7254.2005.00008.x
Saerens, 2008, Curr Opin Pharmacol, 8, 600, 10.1016/j.coph.2008.07.006
Gebauer, 2009, Curr Opin Chem Biol, 13, 245, 10.1016/j.cbpa.2009.04.627
Friedman, 2009, Biotechnol Appl Biochem, 54, 121, 10.1042/BA20090096
Rossi, 2006, Proc Natl Acad Sci U S A, 103, 6841, 10.1073/pnas.0600982103
Gold, 2008, Cancer Res, 68, 4819, 10.1158/0008-5472.CAN-08-0232
Zeidler, 1999, J Immunol, 163, 1246, 10.4049/jimmunol.163.3.1246
Sebastian, 2009, J Immunother, 32, 195, 10.1097/CJI.0b013e318195b5bb
Ströhlein, 2009, J Exp Clin Cancer Res, 28, 18, 10.1186/1756-9966-28-18
Kiewe, 2008, Expert Opin Investig Drugs, 17, 1553, 10.1517/13543784.17.10.1553
Shen, 2008, Curr Opin Mol Ther, 10, 273
Kiewe, 2006, Clin Cancer Res, 12, 3085, 10.1158/1078-0432.CCR-05-2436
Gall, 2005, Exp Hematol, 33, 452, 10.1016/j.exphem.2005.01.007
Dreier, 2003, J Immunol, 170, 4397, 10.4049/jimmunol.170.8.4397
Schlereth, 2006, Cancer Immunol Immunother, 55, 503, 10.1007/s00262-005-0001-1
Schlereth, 2006, Cancer Immunol Immunother, 55, 785, 10.1007/s00262-005-0082-x
Lutterbuese, 2009, J Immunother, 32, 341, 10.1097/CJI.0b013e31819b7c70
Bargou, 2008, Science, 321, 974, 10.1126/science.1158545
Haas, 2009, Immunobiology, 214, 441, 10.1016/j.imbio.2008.11.014
Amann, 2009, J Immunother, 32, 452, 10.1097/CJI.0b013e3181a1c097
Amann, 2009, Cancer Immunol Immunother, 58, 95, 10.1007/s00262-008-0529-y
Bühler, 2008, Cancer Immunol Immunother, 57, 43, 10.1007/s00262-007-0348-6
Bühler, 2009, J Immunother, 32, 565, 10.1097/CJI.0b013e3181a697eb
Grosse-Hovest, 2003, Eur J Immunol, 33, 1334, 10.1002/eji.200323322
Otz, 2009, Leukemia, 23, 71, 10.1038/leu.2008.271
Lu, 2004, J Biol Chem, 279, 2856, 10.1074/jbc.M310132200
Lu, 2005, J Biol Chem, 280, 19665, 10.1074/jbc.M500815200
Jimenez, 2005, Mol Cancer Ther, 4, 427, 10.4161/cbt.4.4.1620
Robinson, 2008, Br J Cancer, 99, 1415, 10.1038/sj.bjc.6604700
Vallera, 2009, Leuk Res, 33, 1233, 10.1016/j.leukres.2009.02.006
Bostrom, 2009, Science, 323, 1610, 10.1126/science.1165480
Goldenberg, 2007, Update Cancer Ther, 2, 19, 10.1016/j.uct.2007.04.003
Chatal, 2006, J Clin Oncol, 24, 1705, 10.1200/JCO.2005.04.4917
Balkwill, 2009, Nat Rev Cancer, 9, 361, 10.1038/nrc2628
Grünhagen, 2009, Recent Results Cancer Res, 179, 257, 10.1007/978-3-540-77960-5_16
Hallahan, 1995, Cancer J Sci Am, 1, 204
Azria, 2003, Br J Cancer, 89, 1987, 10.1038/sj.bjc.6601362
Larbouret, 2007, Int J Radiation Oncol Biol Phys, 69, 1231, 10.1016/j.ijrobp.2007.07.2372
Kontermann, 2009, Biodrugs, 23, 93, 10.2165/00063030-200923020-00003
Stork, 2008, J Biol Chem, 283, 7804, 10.1074/jbc.M709179200
Chapman, 2002, Adv Drug Deliv Rev, 54, 531, 10.1016/S0169-409X(02)00026-1
Stork, 2009, J Biol Chem, 284, 25612, 10.1074/jbc.M109.027078
Schlapschy, 2007, Protein Eng Des Sel, 20, 273, 10.1093/protein/gzm020
Marvin, 2005, Acta Pharmacol Sci, 26, 649
Müller, 2007, J Biol Chem, 282, 12650, 10.1074/jbc.M700820200
Stork, 2007, Protein Eng Des Sel, 20, 569, 10.1093/protein/gzm061
Tijnk, 2008, Mol Cancer Ther, 7, 2288, 10.1158/1535-7163.MCT-07-2384
Holt, 2008, Protein Eng Des Sel, 21, 283, 10.1093/protein/gzm067
Kufer, 2004, Trends Biotechnol, 22, 238, 10.1016/j.tibtech.2004.03.006
Melero, 2007, Nat Rev Cancer, 7, 95, 10.1038/nrc2051
Blanco, 2003, J Immunol, 171, 1070, 10.4049/jimmunol.171.2.1070
Müller, 2008, J Immunother, 31, 714, 10.1097/CJI.0b013e31818353e9
